Drugs / CT-010
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04153175 | Aug 2020 → Mar 2024 | epilepsy | Cerebral Therapeutics LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT-010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04153175 ↗ |
| Route | Other | “ICV administration of CT-010” NCT04153175 ↗ |